Xenograft Model Antitumor Assays | ISHAR Online  Xenograft Model Antitumor Assays | ISHAR Online
The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model. ... Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. ... We analyzed the anti-tumor effects of artesunate in metastasizing breast carcinoma in vitro and in vivo. ... Herein we report the identification of artesunate (ART), a derivative of artemisinin, as a potent and selective antitumor agent ...
more infohttp://isharonline.org/tags/xenograft-model-antitumor-assays
Xenograft Model Antitumor Assays | Profiles RNS  Xenograft Model Antitumor Assays | Profiles RNS
"Xenograft Model Antitumor Assays" by people in this website by year, and whether "Xenograft Model Antitumor Assays" was a major ... "Xenograft Model Antitumor Assays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH ( ... Xenograft Model Antitumor Assays*Xenograft Model Antitumor Assays. *Tumor Xenograft Assay. *Xenograft Antitumor Assays ... Below are the most recent publications written about "Xenograft Model Antitumor Assays" by people in Profiles. ...
more infohttps://profiles.rush.edu/display/29241
Research Keyword Faculty Listing | Yale School of Medicine  Research Keyword Faculty Listing | Yale School of Medicine
Xenograft Model Antitumor Assays. Stephanie Halene, MD, PhD Associate Professor of Medicine (Hematology) ... Alternative Splicing; Hematopoiesis; Leukemia; Myelodysplastic Syndromes; Myelopoiesis; Xenograft Model Antitumor Assays View ...
more infohttps://medicine.yale.edu/research/listing.aspx?meshId=19502
A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.  A small-molecule IAP inhibitor overcomes resistance to cytotoxic therapies in malignant gliomas in vitro and in vivo.
Xenograft Model Antitumor Assays. Chemical. Reg. No./Substance: 0/Antineoplastic Agents; 0/Inhibitor of Apoptosis Proteins; 0/ ... In vitro assays demonstrated that LBW242 enhanced the cytotoxic activity of radiotherapy, and clonogenic assays showed that the ... Neurosphere assays revealed that the combination of radiation and LBW242 led to a pro-apoptotic effect in these glioma- ... Athymic mice bearing established human malignant glioma tumor xenografts treated with LBW242 plus radiation and temozolomide ...
more infohttp://www.biomedsearch.com/nih/small-molecule-IAP-inhibitor-overcomes/21724651.html
Tissue-Specific Stem Cells & Therapy | Yale Stem Cell Center | Yale School of Medicine  Tissue-Specific Stem Cells & Therapy | Yale Stem Cell Center | Yale School of Medicine
Alternative Splicing; Hematopoiesis; Leukemia; Myelodysplastic Syndromes; Myelopoiesis; Xenograft Model Antitumor Assays * ...
more infohttps://medicine.yale.edu/stemcell/people/research/therapy.aspx
High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma. | CureHunter  High dose intermittent sorafenib shows improved efficacy over conventional continuous dose in renal cell carcinoma. | CureHunter
Xenograft Model Antitumor Assays. Join CureHunter, for free Research Interface BASIC access!. ... we studied the effects of increased sorafenib dose and intermittent scheduling in a murine RCC xenograft model. ... Mice bearing xenografts derived from the 786-O RCC cell line were treated with sorafenib according to multiple doses and ... sorafenib dosing schedule involving higher dose intermittent treatment appeared to improve its efficacy in this xenograft model ...
more infohttp://www.curehunter.com/public/pubmed22188900.do
Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy. | CureHunter  Plant thymidine kinase 1: a novel efficient suicide gene for malignant glioma therapy. | CureHunter
Xenograft Model Antitumor Assays (methods) Join CureHunter, for free Research Interface BASIC access!. ... In addition, when neural progenitor cells were used as delivery vectors for toTK1 in intracranial GBM xenografts in nude rats, ...
more infohttp://www.curehunter.com/public/pubmed20154339.do
MiR-139-5p inhibits CRC invasion via directly targeting | Open-i  MiR-139-5p inhibits CRC invasion via directly targeting | Open-i
Xenograft Model Antitumor Assays. Related in: MedlinePlus. © Copyright Policy - OpenAccess Related In: Results - Collection ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC4225484_13238_2014_93_Fig5_HTML&req=4
Catechins induced caspase activation, Bcl-xL downregula | Open-i  Catechins induced caspase activation, Bcl-xL downregula | Open-i
In the murine xenograft model, Catechins remarkably inhibited tumor growth and induced in situ leukemic cell apoptosis. ... Cell viability and cell apoptosis were analyzed using MTT assay and flow cytometric assay, respectively. Expression of proteins ... In vivo anti-tumor activity of Catechins was examined in nude mice xenografted with NB4 cells and in situ cell apoptosis was ... In the murine xenograft model, Catechins remarkably inhibited tumor growth and induced in situ leukemic cell apoptosis. ...
more infohttps://openi.nlm.nih.gov/detailedresult.php?img=PMC4197244_13045_2014_75_Fig3_HTML&req=4
recurrent kaposis sarcoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine  recurrent kaposi's sarcoma drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Xenograft Model Antitumor Assays. *HIV InSite. treatment guidelines - Human Herpesvirus-8 .. *Hazardous Substances Data Bank. ... This agent showed remarkable antitumor activity in AIDS-Kaposi's sarcoma, glioblastoma multiforme, and breast cancer models in ... NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .. *NCI CPTC Antibody Characterization Program. NCI CPTC Antibody ... Models, Biological. Sarcoma, Kaposi / drug therapy. Sarcoma, Kaposi / pathology. Time Factors. *MedlinePlus Health Information ...
more infohttp://www.bmlsearch.com/?kwr=recurrent+kaposi
malignant eye neoplasm nos drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine  malignant eye neoplasm nos drug therapy 2000:2010[pubdate] *count=100 - BioMedLib™ search engine
Antitumor. Humans. Male. Mice. Mice, Inbred ICR. Mice, SCID. Tumor Cells, Cultured. Xenograft Model Antitumor Assays ... NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .. *[Email] Email this result item Email the results to the following email ... NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .. *[Email] Email this result item Email the results to the following email ... Therapeutic effect was evaluated in a xenograft model of retinoblastoma.. * RESULTS: Several FDA-approved drugs were identified ...
more infohttp://www.bmlsearch.com/?kwr=malignant+eye+neoplasm+nos+drug+therapy+2000:2010%5Bpubdate%5D&cxts=100&stmp=b1
ZFIN Publication: White et al., 2011  ZFIN Publication: White et al., 2011
Xenograft Model Antitumor Assays; Zebrafish/embryology; Zebrafish/genetics ... DHODH inhibition led to a marked decrease in melanoma growth both in vitro and in mouse xenograft studies. Taken together, ... Disease Models, Animal; Gene Expression Regulation, Neoplastic; Genes, p53/genetics; Humans; Isoxazoles/pharmacology; ...
more infohttp://zfin.org/ZDB-PUB-110426-15
ZFIN Publication: Hsu et al., 2017  ZFIN Publication: Hsu et al., 2017
Xenograft Model Antitumor Assays. *Zebrafish. *Zebrafish Proteins/genetics. PubMed:. 28196873 Full text @ Clin. Cancer Res. ... Zebrafish model was applied for evaluating the synergistic effect of combinatory drugs for overcoming cetuximab resistance. ...
more infohttps://zfin.org/ZDB-PUB-170216-4
The novel organic arsenical darinaparsin induces MAPK-mediated and SHP by Dashnamoorthy Ravi, Savita Bhalla et al.  "The novel organic arsenical darinaparsin induces MAPK-mediated and SHP" by Dashnamoorthy Ravi, Savita Bhalla et al.
Jurkat and L540-derived xenografts in SCID mice were examined for in vivo tumor inhibition and survival. Biologic effects of ... In vivo experiments with Jurkat (TCL) and L540 (HL)-derived lymphoma xenografts showed significant inhibition of tumor growth ... were examined for in vitro cell death by MTT assay and Annexin V-based flow cytometry. ... Xenograft Model Antitumor Assays ... Jurkat and L540-derived xenografts in SCID mice were examined ...
more infohttps://escholarship.umassmed.edu/ssp/209/
Intratumoral injection of alpha-gal glycolipids induces xenograft-like by Uri Galili, Kim Wigglesworth et al.  "Intratumoral injection of alpha-gal glycolipids induces xenograft-like" by Uri Galili, Kim Wigglesworth et al.
The binding of anti-Gal to alpha-gal epitopes on pig cells mediates xenograft rejection. The proposed method uses glycolipid ... of anti-Gal to alpha-gal expressing tumor cells induces the destruction of treated lesions as in anti-Gal-mediated xenograft ... Xenograft Model Antitumor Assays ... anti-Gal to alpha-gal epitopes on pig cells mediates xenograft ... APC further cross-present immunogenic tumor Ag peptides and elicit a systemic anti-tumor immune response. Similar intratumoral ...
more infohttps://escholarship.umassmed.edu/oapubs/1295/
Haojie Huang, PhD - Research Output
     - Mayo Clinic  Haojie Huang, PhD - Research Output - Mayo Clinic
Xenograft Model Antitumor Assays Potassium Channels 35 Citations (Scopus) Measure transcript integrity using RNA-seq data. Wang ...
more infohttps://mayoclinic.pure.elsevier.com/en/persons/haojie-huang/publications/
Synapse - CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a...  Synapse - CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a...
... xenograft model antitumor assays; monoclonal antibody; gene expression regulation; b cell lymphoma; plasma cell; lymphoma, b- ... is specific for the low-affinity IgG Fc receptor CD32B and effective in a human CD32B+ B-cell lymphoma murine xenograft model. ... animal model; relapse; recurrence; dexamethasone; melphalan; amyloidosis; autologous stem cell transplantation; drug screening ... cell; membrane antigen; biosynthesis; immunology; antibodies, monoclonal; xenograft; reverse transcriptase polymerase chain ...
more infohttps://synapse.mskcc.org/synapse/works/15693
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian ca by Miriana Hijaz, Soumen Das et al.  "Folic acid tagged nanoceria as a novel therapeutic agent in ovarian ca" by Miriana Hijaz, Soumen Das et al.
Moreover, NCe-FA was also effective in reducing proliferation and angiogenesis in the xenograft mouse model. CONCLUSION: Thus, ... Immunohistochemistry and toxicity assays were used to evaluate treatment effects. RESULTS: We show that folic acid conjugation ... In vivo studies were carried in A2780 generated mouse xenografts treated with 0.1 mg/Kg NCe, 0.1 mg/Kg; NCe-FA and cisplatinum ... without affecting cell proliferation and significantly reduced tumor growth in an ovarian cancer xenograft nude model. ...
more infohttps://scholarlycommons.henryford.com/neurology_articles/292/
Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.  Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell Carcinoma In Vivo with Susceptibility Contrast MRI.
Xenograft Model Antitumor Assays. en_US. dc.title. Monitoring the Vascular Response and Resistance to Sunitinib in Renal Cell ... SC-MRI of 786-0 xenografts prior to and 2 weeks after daily treatment with 40 mg/kg sunitinib revealed a 71% (P , 0.01) ... In conclusion, SC-MRI enabled monitoring of the antiangiogenic response of 786-0 RCC xenografts to sunitinib, which revealed ... We also interrogate the vascular phenotype of RCC xenografts exhibiting acquired resistance to sunitinib. ...
more infohttps://repository.icr.ac.uk/handle/internal/2683?show=full